Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	29.61	-403.37	-573.04
Graham Fair Price	41.42	2.24	1.59
PEG	-78.50	-0.01	0.05
Price/Book	39.44	-1.21	-2.00
Price/Cash Flow	80.79	-41.49	-215.99
Prices/Earnings	69.72	-1.10	-3.62
Price/Sales	-70.55	10.00	33.95
Price/FCF	80.79	-41.49	-215.99
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	29.61	0.11	0.08
Operating Margin	10.24	-0.33	-0.36
ROA	-100.00	-0.06	-0.03
ROE	0.14	0.28	100.00
ROIC	< 0.005	-0.01	-84.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-89.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.81	-0.85	4.99
EPS QOQ	0.77	-1.08	40.83
FCF QOQ	0.80	-2.15	167.86
Revenue QOQ	-0.39	1.06	174.01
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	989.51	494.76	-50.00
Days Sales Outstanding (DSO)	72.55	69.77	-3.84
Inventory Turnover	0.09	0.18	100.00
Debt/Capitalization	1.26	1.26	-0.02
Quick Ratio	0.16	0.22	36.16
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-0.90	-0.90	< 0.005
Cash	0.07	0.07	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	< 0.005	-0.03	-215.25
Revenue	0.05	0.11	105.63
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.95	0.95	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-404.91	-322.38	20.38
Naive Interpretation	Member

06 - Financial Health · Bad

Rating